9 ms·
Most likely, yes. It's not generally available outside of Japan (and China where it has also been tested) so not much point in adding it to a global trial.
by Mvandenbergh 7y ago
Most likely, yes. It's not generally available outside of Japan (and China where it has also been tested) so not much point in adding it to a global trial.
- funklute 7y agoIs that due to licensing issues or manufacturing capacity?
- dis-sys 7y agomore to do with the side effect. it causes birth defects in pretty alarming rate. Japanese government only allows it to be used as a backup, Chinese licensed the design but the government only allows it to be used when all other avenues are exhausted.
- Grue3 7y agoAren't most severe patients elderly? Why would birth defects be a problem at this point?
- vonmoltke 7y agoThat isn't the issue; it's that this drug is not available at all outside of those two countries. Side effects are the reason it isn't. The WHO is prioritizing drugs with worldwide availability.
- deleted 7y ago[deleted]
- jokowueu 7y agoKuwait just recently bought a large amount of the drug .
- megous 7y agoUnlikely the reason, since the no 1. on the list is not globally available either. But I guess things can change quickly.